Search for: "MICHAEL MCNEIL"
Results 81 - 94
of 94
Sort by Relevance
|
Sort by Date
28 Apr 2008, 11:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Apr 2008, 2:00 am
, Global Global - General Candidates for post of WIPO Director General present their platforms: (WIPO), IP is not a thing: (Dilanchian), FOSS adoption and consumer welfare: (IPcentral) Global - Trade Marks / Domain Names / Brands Manufacturers becoming brand licensing companies: (IP ThinkTank), Anti-Counterfeiting Trade Agreement moves forward: (Michael Geist) Global - Patents Office Open XML voted to become official standard, so out of Microsoft’s… [read post]
11 Apr 2008, 9:00 am
Forest Laboratories, Inc. turns law of declaratory judgment on its head: (Patent Docs), (Patent Baristas), Mircera (Methoxy polyethylene glycol-epoetin beta) – Roche appeals preliminary injunction barring US sales of Mircera in patent infringement battle with Amgen: (Philip Brooks), (IP Law360), Norvasc (Amlodipine) – Ranbaxy becomes first foreign generic company to develop a generic product independently outside Japan and receive authorization from MHLW-Japan:… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of… [read post]
5 Jan 2008, 6:00 am
,Public Domain Day 2008: (CopyrightWatch.ca),Quebec bloggers on Canadian DMCA: (Michael Geist),Industry Minister, Jim Prentice, calls for ‘extensive copyright discussions' after the Canadian DMCA is introduced: (Michael Geist)ChinaDanone / Wahaha: Both parties agree to truce: (Managing the Dragon),Both Baidu.com and Yahoo China provided deep links to pirated mp3's, Baidu won in court, while Yahoo China… [read post]
19 Dec 2007, 12:43 pm
LeClaire Steven Andrew Light Arlinda Locklear Michael Lombardi Deron Marquez Heidi McNeil Staudenmaier Kathryn R.L. [read post]
4 Sep 2007, 8:16 am
The president of the Institute for Safe Medication Practices, Michael R. [read post]
5 Jul 2007, 10:37 am
Michael Reese Hospital & Medical Center, 513 N.E.2d 387, 393 (Ill. 1987).Kansas: Savina v. [read post]
11 May 2007, 12:52 am
McNeil Nutritionals. [read post]
10 May 2007, 10:39 am
State of Indiana (NFP) Amanda McNeil v. [read post]
7 Feb 2007, 9:49 am
Michael Lewis' book The Blind Side points out the sharp increase in pay for NFL left tackles over the past decade or so. [read post]
2 Oct 2005, 9:55 am
A Working Luncheon -- Sponsored by ALM--Philadelphia Region Moderated by attorney Steven Silverberg, a panel of experienced brand marketers from three perspectives debate and teach – Bob Gero, Director of Business Development at Milbank Tweed (the law firm); Alan Sharavsky of Sharavsky Communications (the marketing communications agency); and Ivy Brown, Splenda ® Franchise Director, McNeil Nutritionals/Johnson & Johnson (Fortune 100 Corporate Brander). [read post]
